Explore our featured news items here. Subscribe to stay informed of all information shared and published by DHC.

Sponsor appreciation:

You’re invited to explore and join Physician Factor, a knowledge exchange network is a dedicated portal for physicians seeking opportunities to contribute their expertise and input in exchange for compensation and supplemental income.

You can search articles using your own keywords or the following tags: Type 1 | Type 2 | Research | Drugs and Therapies

NYITCOM Physician: Diabetes Patients Should Heed FDA Warning
DHC Author DHC Author

NYITCOM Physician: Diabetes Patients Should Heed FDA Warning

In late February, the Food and Drug Administration (FDA) warned diabetes patients not to use smartwatches or smart rings to measure their blood glucose levels. Following the FDA’s alert, obesity medicine expert Eleanor Yusupov, D.O., assistant professor at the College of Osteopathic Medicine, shares valuable insight for these patients.

Read More
Diabetes and Liver Cancer — Stanford Medicine Study Suggests New Screening Guidelines
DHC Author DHC Author

Diabetes and Liver Cancer — Stanford Medicine Study Suggests New Screening Guidelines

A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines. Researchers at Stanford University have shown that another biophysical characteristic known as viscoelasticity — think of how stretching a ball of Silly Putty or a clump of bread dough is met at first with resistance, and then with release — is even more tightly correlated with liver cancer than stiffness, particularly in people with Type 2 diabetes.

Read More
Virginia Tech Researchers Awarded Nearly $2 Million To Explore New Treatment for Type 2 Diabetes and Obesity
DHC Author DHC Author

Virginia Tech Researchers Awarded Nearly $2 Million To Explore New Treatment for Type 2 Diabetes and Obesity

A team of Virginia Tech researchers was awarded nearly $2 million from the National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health, to explore novel approaches for treating Type 2 diabetes and obesity. The team of researchers, led by principal investigator Dongmin Liu, will study the impact of a derivative of secoiridoid, a natural compound found in certain plants like olives, on blood sugar control and obesity, which are often precursors to Type 2 diabetes.

Read More
Transforming Diabetes Care with Precision Medicine
DHC Author DHC Author

Transforming Diabetes Care with Precision Medicine

“Precision medicine” involves customizing interventions to the unique genetic and molecular makeup of individual patients rather than relying on symptoms or broad categories. This approach, long associated with cancer treatment, is becoming increasingly critical for diabetes prevention and care. Precise diagnosis and disease characterization affect not only treatment choices but life planning, other health considerations, and even family members’ well-being. It means providing the right diagnosis, best care and insights into outcomes for all people with diabetes.

Read More
What Is Insulin Resistance and How Do You Know if You Have It?
DHC Author DHC Author

What Is Insulin Resistance and How Do You Know if You Have It?

According to the Centers for Disease Control and Prevention, 37.3 million adults have diabetes and 96 million — or more than one-third of Americans — have pre-diabetes. Because insulin resistance is a precursor to both, researchers estimate the number of people with insulin resistance is much higher.. “Most people don’t even know that they have it,” said Dr. Mary Vouyiouklis Kellis, an endocrinologist at Cleveland Clinic.

Read More
Scientists Target Human Stomach Cells for Diabetes Therapy
DHC Author DHC Author

Scientists Target Human Stomach Cells for Diabetes Therapy

Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study from researchers at Weill Cornell Medicine.

Read More
Too Much Insulin Can Be As Dangerous As Too Little
DHC Author DHC Author

Too Much Insulin Can Be As Dangerous As Too Little

One hundred years of research have greatly advanced medical and biochemical understanding of how insulin works and what happens when it is lacking, but the reverse, how potentially fatal insulin hyper-responsiveness is prevented, has remained a persistent mystery. In a new study, published in the April 20, 2023 online edition of Cell Metabolism, a team of scientists at the University of California San Diego School of Medicine, with colleagues elsewhere, describe a key player in the defense mechanism that safeguards us against excessive insulin in the body.

Read More
Different Ways to Provide Better Health Care for Diabetic Patients
DHC Author DHC Author

Different Ways to Provide Better Health Care for Diabetic Patients

Health care providers play a crucial role in helping their patients prevent or delay type 2 diabetes and manage all types of diabetes. The following resources can support your efforts to screen, test, and refer people to type 2 diabetes prevention and diabetes management programs and services.

Read More